CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting Nov 19, 2020 8:00am EST
CNS Pharmaceuticals Announces FDA Filing of IND for its Brain Cancer Drug Berubicin Nov 17, 2020 8:00am EST
CNS Pharmaceuticals to Discuss Phase 2 Clinical Trial Design to be Submitted for FDA Review in Webcast at 4:30 PM ET Today Nov 12, 2020 8:00am EST
CNS Pharmaceuticals Announces Adaptive Trial Design For Berubicin Phase 2 Clinical Trial To Be Submitted for FDA Review Nov 09, 2020 8:00am EST
CNS Pharmaceuticals Completes Manufacturing of Berubicin for Phase 2 Clinical Trial Oct 29, 2020 8:00am EDT
CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin for Phase 2 Clinical Trial Oct 20, 2020 8:00am EDT
CNS Pharmaceuticals Highlights New Balancing Act Segment on Glioblastoma Airing on Lifetime TV Oct 12, 2020 8:00am EDT
